Literature DB >> 35186678

Novel mutations in the BEST1 gene cause distinct retinopathies in two Chinese families.

Zhi-Hong Zhu1, Xin Jin2, Yi-Xin Zhang3, Rui Wang1, Tong Wu1, Wei Liu1, Ze-Hua Chen1, Hai-Nan Xie1, Lan-Lan Chen1, Zi-Hao Liu4, Hou-Bin Huang1,2,5.   

Abstract

AIM: To describe the clinical heterogeneity of patients with novel mutations in BEST1.
METHODS: All the members in the two Chinese families underwent detailed clinical evaluations including best-corrected visual acuity, slit-lamp examination, applanation tonometry, and dilated fundus examination. Fundus autofluorescence, fundus fluorescein angiography, spectral-domain optical coherence tomography, electrooculography, and electroretinogram were also performed. Genomic DNA was extracted from venous blood for all the participants. The targeted next-generation sequencing of inherited retinal disease-associated genes was conducted to identify the causative mutation.
RESULTS: A novel BEST1 missense mutation c.41T>C (p.Leu14Ser) was identified in Family 1. It was co-segregated with the phenotype of best vitelliform macular dystrophy (BVMD) and bioinformatics analysis confirmed it was harmful. Another novel BEST1 frameshift mutation c.345_346insGGCAAGGACG (p.Glu119Glyfs*116) and a novel USH2A missense mutation c.12560G>A, p.Arg4187His were identified in family 2 with retinitis pigmentosa (RP), which might interact and lead to the phenotype of RP.
CONCLUSION: Two novel mutations in the BEST1 gene in two unrelated families with distinct phenotypes and BEST1 mutation accompanied with USH2A mutation would result in RP, which could be enormously helpful in understanding the pathogenesis of the inherited retinal disease caused by a BEST1 mutation. International Journal of Ophthalmology Press.

Entities:  

Keywords:  BEST1 gene; best vitelliform macular dystrophy; gene mutation; retinitis pigmentosa

Year:  2022        PMID: 35186678      PMCID: PMC8818453          DOI: 10.18240/ijo.2022.02.03

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  30 in total

1.  Disease-causing mutations associated with bestrophinopathies promote apoptosis in retinal pigment epithelium cells.

Authors:  Tingting Gao; Chengqiang Tian; Hui Xu; Xin Tang; Lvzhen Huang; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-07       Impact factor: 3.117

2.  Autosomal dominant vitreoretinochoroidopathy.

Authors:  S J Kaufman; M F Goldberg; D H Orth; G A Fishman; H Tessler; K Mizuno
Journal:  Arch Ophthalmol       Date:  1982-02

3.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

4.  Bestrophin1: A Gene that Causes Many Diseases.

Authors:  Joseph J Smith; Britta Nommiste; Amanda-Jayne F Carr
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Phenotypic and Genetic Spectrum of Autosomal Recessive Bestrophinopathy and Best Vitelliform Macular Dystrophy.

Authors:  Tyler A Pfister; Wadih M Zein; Catherine A Cukras; Hatice N Sen; Ramiro S Maldonado; Laryssa A Huryn; Robert B Hufnagel
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-05-03       Impact factor: 4.799

6.  Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.

Authors:  Alan D Marmorstein; Tyson R Kinnick; J Brett Stanton; Adiv A Johnson; Ronald M Lynch; Lihua Y Marmorstein
Journal:  Mol Vis       Date:  2015-04-01       Impact factor: 2.367

7.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

8.  Retinitis pigmentosa associated with a mutation in BEST1.

Authors:  Lauren A Dalvin; Jackson E Abou Chehade; John Chiang; Josefine Fuchs; Raymond Iezzi; Alan D Marmorstein
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-30

9.  BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure.

Authors:  Karina E Guziewicz; Artur V Cideciyan; William A Beltran; András M Komáromy; Valerie L Dufour; Malgorzata Swider; Simone Iwabe; Alexander Sumaroka; Brian T Kendrick; Gordon Ruthel; Vince A Chiodo; Elise Héon; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

10.  Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations.

Authors:  Changyi Ji; Yao Li; Alec Kittredge; Austin Hopiavuori; Nancy Ward; Peng Yao; Yohta Fukuda; Yu Zhang; Stephen H Tsang; Tingting Yang
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.